2 November, 2021
Dr. Antonio de Lacy’s team at Hospital Clínic is a global point of reference in transanal surgery
Surgical techniques are constantly evolving in order to improve the results while minimising the consequences caused by the intervention. One of the routes that is followed to achieve this last step is by reducing, where possible, the incisions employed in order to carry out the intervention. In this regard the approaches that take advantage of the natural orifices of the patient are being used more and more. Transanal total mesorectal excision or TaTME is one of these techniques, developed by the team lead by Dr. Antonio de Lacy, head of the Gastrointestinal Surgery Service at Hospital Clínic of Barcelona and oncology surgeon at barnaclínic+, it is currently considered one of the best treatment options for patients with colon and rectal cancer. Read more…
25 March, 2021
The Hospital Clínic Group, pioneer and leader in robotic surgery
Greater precision in surgery and reduced risks and complications during interventions result in better outcomes for patients. This is what robotic surgery provides, one of the great advances that technological developments in medicine have made possible in recent years. One of the centres that has made the most significant commitment to this type of surgery is the Hospital Clínic Group and barnaclínic+.
23 May, 2018
Peritoneal carcinomatosis: What is it and what is its treatment?
The term Peritoneal carcinomatosis or Peritoneal carcinosis (PC) is given to every local or massive tumor dissemination affecting the peritoneal serosa and neighboring organs. It usually has two origins: the peritoneum itself (Pseudomyxoma, Mesothelioma) and digestive tract or gynecological tumors.
